# Biocryst Pharmaceuticals Inc: Form 8-K, filed Sep 30, 2024

- Company: [Biocryst Pharmaceuticals Inc](/companies/bcrx.md) (CIK 882796)
- Form: 8-K
- Filed: 2024-09-30
- Accepted by EDGAR: Sep 30, 2024, 07:11 ET
- Period: 2024-09-30
- Accession: 0001171843-24-005393
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/882796/000117184324005393/f8k_093024.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882796/000117184324005393/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882796/000117184324005393/f8k_093024.htm

Filed Sep 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001171843-24-005393. Last ingested by Listed: Nov 4, 2026, 16:44 ET. No prices; not investment advice.